Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Directors' Dealings

10 Mar 2017 16:14

RNS Number : 1953Z
Premier Veterinary Group PLC
10 March 2017
 

 

 

 

PREMIER VETERINARY GROUP PLC

 

("PVG" or the "Company")

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

 

 

London, UK, 10 March 2017 (LSE: PVG): Following interest in the Company from a number of institutional investors, and with the aim of increasing the liquidity of the Company's shares, certain directors of PVG have sold, in aggregate, 2,350,000 ordinary shares of 10 pence each at a price of 225 pence per ordinary share. The number of ordinary shares sold by each director and their remaining interest in ordinary shares is set out below. Following this share disposal, these directors have no current intention of selling any further shares in PVG.

Director

Number of Shares Sold

Dominic Tonner

619,167

Rajan Uppal

1,614,749

Iain Ross

116,084

 

Following these trades, the interests of those directors in ordinary shares of PVG are as follows:

 

Director

Number of Ordinary Shares of 10p each

Percentage of Issued Share Capital

 

Dominic Tonner

1,799,670

12.07%

Rajan Uppal

5,421,138

36.37%

Iain Ross

389,725

2.61%

 

All shares are held beneficially.

 

In order to facilitate the share disposals, Messrs Tonner and Uppal today transferred shares from the following former nominee accounts to nominee accounts held with the Company's brokers, Investec Bank plc as follows:

 

Director

Former nominee account

Number of shares transferred

Dominic Tonner

Thomas Grant & Company Nominees Ltd

*2,418,837

Rajan Uppal

Vidacos Nominees Limited

6,248,500

 

* including 66,000 shares held by Mr Tonner's spouse.

 

Following the transfers and subsequent disposals, the remaining shares held by Messrs Tonner and Uppal are divided between the following nominee accounts:

 

Director

Nominee account

Number of shares

Dominic Tonner

Investec Bank plc

*1,799,670

Rajan Uppal

Investec Bank plc

4,633,751

Rajan Uppal SIPP

Vidacos Nominees Limited

651,500

Rajan Uppal

Thomas Grant & Company Nominees Ltd

63,387

Rajan Uppal ISA

Lynchwood Nominees Ltd

60,000

Tracey Uppal ISA

Lynchwood Nominees Ltd

12,500

 

The Company's issued share capital as at the date of this notification is 14,907,433 ordinary shares of 10 pence each.

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail:

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Dominic TONNER

2

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer/Executive Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Premier Veterinary Group plc

 

b)

LEI

 2138009B5L8VQUZ9A719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.10 each

 

 

 

ISIN: GB00BSZLMS59

b)

Nature of the transaction

Transfer of shares from nominee accounts held with Thomas Grant & Company Nominees Ltd to nominee account held with Investec Bank Plc, including 66,000 shares held by spouse. There was no change in beneficial ownership. 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

N/A

2,418,837

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

 Aggregate Price

Aggregate Volume

Aggregate Total

 

N/A

N/A

N/A

e)

Date of the transaction

10 March 2017

 

f)

Place of the transaction

Outside of trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Rajan UPPAL

2

Reason for the notification

 

a)

Position/status

 

Corporate Development Director/Executive Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Premier Veterinary Group plc

 

b)

LEI

 2138009B5L8VQUZ9A719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.10 each

 

 

 

ISIN: GB00BSZLMS59

b)

Nature of the transaction

Transfer of shares from nominee account held with Vidacos Nominees Ltd to nominee account held with Investec Bank Plc. There was no change in beneficial ownership. 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

N/A

6,248,500

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

 Aggregate Price

Aggregate Volume

Aggregate Total

 

N/A

N/A

N/A

e)

Date of the transaction

10 March 2017

 

f)

Place of the transaction

Outside of trading venue

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Dominic TONNER

2

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer/Executive Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Premier Veterinary Group plc

 

b)

LEI

 2138009B5L8VQUZ9A719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.10 each

 

 

 

ISIN: GB00BSZLMS59

b)

Nature of the transaction

Disposal of shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.25

619,167 shares

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

 Aggregate Price

Aggregate Volume

Aggregate Total

 

£-

-

£-

e)

Date of the transaction

10 March 2017

 

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Rajan UPPAL

2

Reason for the notification

 

a)

Position/status

 

Corporate Development Director/Executive Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Premier Veterinary Group plc

 

b)

LEI

 2138009B5L8VQUZ9A719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.10 each

 

 

 

ISIN: GB00BSZLMS59

b)

Nature of the transaction

Disposal of shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.25

1,614,749 shares

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

 Aggregate Price

Aggregate Volume

Aggregate Total

 

£-

-

£-

e)

Date of the transaction

10 March 2017

 

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Iain ROSS

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Premier Veterinary Group plc

 

b)

LEI

 2138009B5L8VQUZ9A719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.10 each

 

 

 

ISIN: GB00BSZLMS59

b)

Nature of the transaction

Disposal of shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.23875

116,084 shares

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

 Aggregate Price

Aggregate Volume

Aggregate Total

 

£-

-

£-

e)

Date of the transaction

10 March 2017

 

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

For further information, please contact:

 

Premier Veterinary Group plc Tel:  +44(0)117 970 4127

 

Dominic Tonner, Chief Executive Officer

Will Evans, Chief Financial Officer

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMGMFVGZGNZM
Date   Source Headline
1st Mar 201310:50 amRNSForm 8.3 - [Ark Therapeutics]
26th Feb 20135:35 pmRNSHolding(s) in Company
26th Feb 20139:33 amRNSForm 8.3 - Ark Therapeutics Group PLC
25th Feb 201311:55 amRNSForm 8.3 - Ark Therapeutics Group PLC
25th Feb 201311:27 amRNSHolding(s) in Company
22nd Feb 20132:41 pmRNSHolding(s) in Company
21st Feb 20131:24 pmPRNForm 8.3 - Ark Therapeutics plc
21st Feb 201310:56 amRNSHolding(s) in Company
20th Feb 201312:54 pmPRNForm 8.3 - Ark Therapeutics plc
20th Feb 201312:11 pmRNSForm 8.3 - [Ark Therapeutics Group PLC]
19th Feb 20134:40 pmRNSSecond Price Monitoring Extn
19th Feb 20134:35 pmRNSPrice Monitoring Extension
15th Feb 201312:57 pmRNSForm 8.3 - Ark Therapeutics Group PLC
15th Feb 201310:39 amPRNForm 8.3 - Ark Therapeutics Group plc
12th Feb 201312:25 pmRNSHolding(s) in Company
7th Feb 20133:05 pmRNSHolding(s) in Company
7th Feb 20131:41 pmPRNForm 8.3 - Ark Therapeutics Group
6th Feb 20134:43 pmRNSForm 8.3 - Ark Therapeutics
6th Feb 201311:18 amPRNForm 8.3 - Ark Therapeutics Group
6th Feb 201311:02 amRNSForm 8 (OPD)
5th Feb 20134:35 pmRNSPrice Monitoring Extension
5th Feb 20132:48 pmRNSForm 8.3 - Ark Therapeutics Group PLC
4th Feb 20132:43 pmRNSForm 8.3 - Ark Therapeutics Group Plc
4th Feb 20131:10 pmRNSForm 8.3 - Ark Therapeutics
4th Feb 201310:11 amRNSForm 8.3 - [Ark Therapeutics]
1st Feb 20133:10 pmRNSForm 8.3 - Ark Therapeutics Group PLC
1st Feb 20132:53 pmRNSForm 8.3 - Ark Therapeutics Amendment
1st Feb 201312:41 pmRNSForm 8.3 - Ark Therapeutics Group plc
31st Jan 20133:42 pmRNSForm 8.3 - Ark Therapeutics Group PLC
31st Jan 20131:40 pmRNSForm 8.3 - Ark Therapeutics Group Plc
31st Jan 20131:31 pmRNSForm 8.3 - Ark Therapeutics Group plc
31st Jan 201312:02 pmRNSForm 8.3 - ARK Therapeutics plc
31st Jan 201311:51 amBUSForm 8.3 - Ark Therapeutics Group Plc
31st Jan 201311:14 amPRNForm 8.3 - Ark Therapeutics Group
30th Jan 20134:03 pmRNSForm 8.3 - Ark Therapeutics Group Plc
30th Jan 20137:00 amRNSStrategic Review Update
24th Jan 20133:33 pmRNSHolding(s) in Company
21st Jan 20137:00 amRNSCompany Update
4th Dec 20123:40 pmRNSBlocklisting Six Monthly Return
30th Nov 20127:00 amRNSFrench Tax Credit for Research and Development
8th Nov 20127:00 amRNSInterim Management Statement
15th Oct 20127:00 amRNSRe Agreement
26th Sep 20127:00 amRNSManufacturing Agreement Update
29th Aug 20127:00 amRNSHalf Yearly Report
24th Aug 20124:40 pmRNSSecond Price Monitoring Extn
24th Aug 20124:35 pmRNSPrice Monitoring Extension
14th Aug 20127:00 amRNSRe Agreement
25th Jul 20127:00 amRNSManufacturing Partnership
5th Jul 20127:00 amRNSDirectorate Change
11th Jun 20127:00 amRNSAppointment of New Head of Business Development

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.